Quick Answer
Insight Molecular Diagnostics Inc. reported Research And Development Expense of $15.90 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +61.6% in Research And Development Expense from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $1.12 million | Q2 2015: $886.0 thousand | Q3 2015: $1.09 million | Q1 2016: $1.69 million | Q2 2016: $1.20 million | Q3 2016: $1.36 million | Q1 2017: $1.83 million | Q2 2017: $2.00 million | Q3 2017: $1.84 million | Q1 2018: $1.46 million | Q2 2018: $2.32 million | Q3 2018: $1.53 million | Q1 2019: $1.34 million | Q2 2019: $1.51 million | Q3 2019: $1.63 million | Q1 2020: $2.16 million | Q2 2020: $3.23 million | Q3 2020: $2.62 million | Q4 2020: $1.80 million | Q1 2021: $125.0 thousand | Q1 2021: $3.36 million | Q2 2021: $2.54 million | Q3 2021: $3.14 million | Q4 2021: $4.59 million | Q1 2022: $2.01 million | Q2 2022: $2.44 million | Q3 2022: $1.47 million | Q1 2023: $2.13 million | Q2 2023: $2.44 million | Q3 2023: $2.19 million | Q1 2024: $2.31 million | Q2 2024: $2.45 million | Q3 2024: $2.82 million | Q1 2025: $2.92 million | Q2 2025: $3.28 million | Q3 2025: $3.88 million.
- Over the full 12 years of available data (2014 to 2025), Insight Molecular Diagnostics Inc.'s Research And Development Expense has grown by 301.3%.
- Historical annual values: Fiscal year 2025: $15.90 million | Fiscal year 2024: $9.84 million | Fiscal year 2023: $9.29 million | Fiscal year 2022: $7.30 million | Fiscal year 2021: $5.04 million | Fiscal year 2020: $9.80 million | Fiscal year 2019: $6.79 million | Fiscal year 2018: $6.51 million | Fiscal year 2017: $7.17 million | Fiscal year 2016: $5.68 million | Fiscal year 2015: $4.53 million | Fiscal year 2014: $3.96 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: